Integrated Mutation, Copy Number and Expression Profiling in Resectable Non-Small Cell Lung Cancer

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-11-93
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Erratum To: ROS1 Gene Rearrangement and Copy Number Gain in Non-Small Cell Lung Cancer

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2015English

Profiling Cancer Testis Antigens in Non–small-Cell Lung Cancer

JCI insight
Medicine
2016English

MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-Stage Non–small Cell Lung Cancer

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2015English

Prognostic Impact of CD8 and Programmed Death-Ligand 1 Expression in Patients With Resectable Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Loss of MKK3 and MK2 Copy Numbers in Non-Small Cell Lung Cancer

Journal of Cancer
Oncology
2016English

Profiling Non-Small Cell Lung Cancer: From Tumor to Blood

Clinical Cancer Research
Cancer ResearchOncology
2015English

Mutations in TP53 Increase the Risk of SOX2 Copy Number Alterations and Silencing of TP53 Reduces SOX2 Expression in Non-Small Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

KRAS Mutation, KRAS–LCS6 Polymorphism, and Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2010English

Impact of Lymph Node Management on Resectable Non-Small Cell Lung Cancer Patients

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy